- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07518069
Factores Genéticos y Biohumorales Implicados en la Enfermedad de Menière y su Correlación con los Fenotipos (Menière09)
Factores Genéticos y Biohumorales en la Enfermedad de Menière
Aim of this work was to assess the role of polymorphisms belonging to genes involved in the regulation of ionic homeostasis in Caucasian patients with Ménière Disease (MD) and compare results with a cohort of patients affected by vestibular migraine and a cohort of non vestibular subjects
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Ménière's Disease (MD) is an inner ear disorder characterized by episodic vertigo, fluctuating sensorineural hearing loss and aural fullness ; endolymphatic hydrops is commonly associated with the pathophysiology of the disorder, although current data support the hypothesis that hydrops is an epiphenomenon associated with different inner ear disorders. The frequency of familial cases has been estimated in the range between 5 and 15% and it has been hypothesized that the disorder may arise from the interplay of genetic and environmental factors. Different candidate genes have been studied, although to date genetic investigation produced no conclusive results .
Among others, considering the importance of ionic homeostasis in the inner ear for the maintenance of endocochlear potential, genetic of fluid and ionic homeostasis have been included. A mutation of KCNQ1 and KCNE1 channels, co-expressed in the inner ear and in the heart, leads to a severe sensorineural deafness and a collapse of the cochlear scala media as seen in Jervell and Lange-Nielsen syndrome.
The aim of this work was to assess the role of genetic polymorphisms located in genes involved in the regulation of ionic transport on an Italian population of patients with definite MD.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Roberto Carlo Teggi, MD
- Número de teléfono: +393921569410
- Correo electrónico: teggi.roberto@hsr.it
Copia de seguridad de contactos de estudio
- Nombre: Laura Zagato, MD
- Número de teléfono: +393406133818
- Correo electrónico: zagato.laura@hsr.it
Ubicaciones de estudio
-
-
Italy
-
Milan, Italy, Italia, 20132
- Reclutamiento
- IRCCS San Raffaele
-
Contacto:
- Roberto Carlo Teggi, MD
- Número de teléfono: +390226432628
- Correo electrónico: teggi.roberto@hsr.it
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Patients were included if they fulfilled criteria for definite unilateral MD according to the Barany Society; in subjects enrolled before 2015 a retrospective analysis of data confirmed Barany criteria
Descripción
Inclusion Criteria:
- Patients with definite Menière's Disease according to the criteria of the Barany Society
Exclusion Criteria:
- surgically treated before the examination or if they had undergone intratympanic therapy with steroids or gentamicin
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: CASE_CONTROL
- Perspectivas temporales: PROSPECTIVE
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Menière's Disease; vestibular migraine
Enrolled subjects should fulfil criteria for definite Menière's Disease (group MD) or definite Vestibular Migraine (VM) according to the ongoing criteria of the Barany Society. Moreover a cohort of non vertiginous subjects will be enrolled. A signed informed consent will be obtained by all subjects. A withdrawal for blood sample will be obtained to study genetic and biohumoral factors in the 3 groups |
A blood withdrawal will be obtained to assess
Otros nombres:
Genetics of ionic transporters and biohumoral factors related to Meniere's Disease and differences with vestibular migraine subjects |
|
Menière's Disease (MD)
To be included, subjects should fulfill definite diagnostic criteria for MD. A blood withdrawal will be obtained to assess genetic and biohumoral aspects |
A blood withdrawal will be obtained to assess
Otros nombres:
Genetics of ionic transporters and biohumoral factors related to Meniere's Disease and differences with vestibular migraine subjects |
|
Vestibular Migraine (VM)
To be included, subjects should fulfill definite diagnostic criteria for VM. A blood withdrawal will be obtained to assess genetic and biohumoral aspects |
A blood withdrawal will be obtained to assess
Otros nombres:
Genetics of ionic transporters and biohumoral factors related to Meniere's Disease and differences with vestibular migraine subjects |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Genetic of ionic transporters
Periodo de tiempo: From enrollment to the end of enrollment in december 2027
|
Genomic DNA of all cases and controls was extracted from venous blood by standard methods. 36 Single Nucleotide Polymorphisms (SNPs) were genotyped using TaqMan® OpenArray™ Genotyping System (Life Technologies, Foster City, CA). All DNA samples were loaded and amplified according to the manufacturer's instructions. |
From enrollment to the end of enrollment in december 2027
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Biohumoral factors specifically Interleukins, Endogenous Ouabain
Periodo de tiempo: From enrollment to the end of the study in july 2027
|
Values of interleukins and endogenous ouabain is evaluated in blood sample of patients and compared with values in blood samples of a control group and in patients with vestibular migraine |
From enrollment to the end of the study in july 2027
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Teggi R, Colombo B, Zagato L, Filippi M. Could ionic regulation disorders explain the overlap between meniere's disease and migraine? J Vestib Res. 2021;31(4):297-301. doi: 10.3233/VES-200788.
- Frejo L, Giegling I, Teggi R, Lopez-Escamez JA, Rujescu D. Genetics of vestibular disorders: pathophysiological insights. J Neurol. 2016 Apr;263 Suppl 1:S45-53. doi: 10.1007/s00415-015-7988-9. Epub 2016 Apr 15.
- Teggi R, Carpini SD, Zagato L. Endolymphatic hydrops and ionic transporters: genetic and biohumoral aspects. J Neurol. 2019 Sep;266(Suppl 1):47-51. doi: 10.1007/s00415-019-09399-6. Epub 2019 Jun 5.
- Teggi R, Zagato L, Delli Carpini S, Citterio L, Cassandro C, Albera R, Yang WY, Staessen JA, Bussi M, Manunta P, Lanzani C. Genetics of ion homeostasis in Meniere's Disease. Eur Arch Otorhinolaryngol. 2017 Feb;274(2):757-763. doi: 10.1007/s00405-016-4375-9. Epub 2016 Nov 11.
- Lopez-Escamez JA, Perez-Carpena P. Update on the pathophysiology, diagnosis and management of Meniere's disease. Curr Opin Otolaryngol Head Neck Surg. 2024 Oct 1;32(5):306-312. doi: 10.1097/MOO.0000000000001002. Epub 2024 Jul 22.
- Frejo L, Lopez-Escamez JA. Cytokines and Inflammation in Meniere Disease. Clin Exp Otorhinolaryngol. 2022 Feb;15(1):49-59. doi: 10.21053/ceo.2021.00920. Epub 2022 Feb 8.
- Teggi R, Battista RA, Di Berardino F, Familiari M, Cangiano I, Gatti O, Bussi M. Evaluation of a large cohort of adult patients with Meniere's disease: bedside and clinical history. Acta Otorhinolaryngol Ital. 2020 Dec;40(6):444-449. doi: 10.14639/0392-100X-N0776.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- GO/URC/ER/mm prot 762
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
A dataset with genetic data will be shared as a excel file
Marco de tiempo para compartir IPD
Initial data will be available in december
Criterios de acceso compartido de IPD
Reviewers for the journal in which the work is submitted. On request, other researchers may access to data
Tipo de información de apoyo para compartir IPD
- RSC
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .